These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10408189)

  • 1. [An unusual cause of hepatorenal symptoms].
    Frank H; Krammer M; Fierlbeck W; Riess R; Geiger H
    Med Klin (Munich); 1999 May; 94(5):274-8. PubMed ID: 10408189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A rare case of cholestasis and macrohematuria in a 52-year-old patient].
    Arkenau HT; Widjaja A
    Med Klin (Munich); 2002 Aug; 97(8):480-3. PubMed ID: 12229247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Crohn's disease and amyloidosis. An association to be considered].
    Sánchez Lombraña JL; Triviño A; Linares A; Navascués CA; Pérez R; Rodríguez M; Rodrigo L
    Rev Esp Enferm Dig; 1991 Nov; 80(5):337-41. PubMed ID: 1768475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis.
    Sethi S; Dasari S; Amin MS; Vrana JA; Theis JD; Alexander MP; Kurtin PJ
    Kidney Int; 2017 Apr; 91(4):964-971. PubMed ID: 28139293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary amyloidosis presenting with cholestasis and hyperkinetic portal hypertension.
    Culafić D; Perisić M; Boricić I; Culafić-Vojinović V; Vukcević M
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):201-4. PubMed ID: 17592572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinicopathological spectrum of renal amyloidosis.
    Hsu JY; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Lian JD
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Oct; 54(4):230-9. PubMed ID: 7982133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Case of AL amyloidosis associated with a remarkable histological progress in a short period].
    Kadoya H; Namba T; Matsuda J; Yamamoto T; Takeji M; Yamauchi A
    Nihon Jinzo Gakkai Shi; 2010; 52(5):590-4. PubMed ID: 20715592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin related amyloidosis presenting as isolated lymph node and pulmonary involvement.
    Meeus G; Ponette J; Delabie J; Verschakelen J; Blockmans D
    Leuk Lymphoma; 2000 Jul; 38(3-4):423-7. PubMed ID: 10830751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Severe recurrent intrahepatic cholestasis in systemic AL amyloidosis without obvious liver involvement: unexplained hepatic toxicity or a case of misdiagnosed liver amyloidosis?].
    Paudice N; Farsetti S; Caroti L; Bandini S; Ciuti G; Tempestini A; Perfetto F; Galli S; Giabbani L; Caldini AL; Bergesio F
    G Ital Nefrol; 2012; 29(1):92-7. PubMed ID: 22388910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary (AA) amyloidosis in Crohn's disease].
    Bulum T; Prkacin I; Cavrić G; Sobocan N; Skurla B; Duvnjak L; Bulimbasić S
    Acta Med Croatica; 2011; 65(3):271-8. PubMed ID: 22359896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic amyloidosis (primary [AL], immunoglobulin light chain): the natural history in 80 patients.
    Gertz MA; Kyle RA
    Am J Med; 1988 Jul; 85(1):73-80. PubMed ID: 3389383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Case of nephrotic syndrome due to AL-type primary amyloidosis associated with renal cell carcinoma].
    Takano M; Suda N; Ichihara A; Konishi K; Sasamura H; Hayashi K; Hashiguchi A; Miyajima A; Murai M; Itoh H
    Nihon Jinzo Gakkai Shi; 2007; 49(8):1014-9. PubMed ID: 18186230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of clinical and pathological characteristics of 28 cases with renal amyloidosis.
    Zhu X; Liu F; Liu Y; Liu H; Xu X; Peng Y; Sun L; Yuan S
    Clin Lab; 2011; 57(11-12):947-52. PubMed ID: 22239026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary (AA) renal/bone amyloidosis complicating rheumatoid arthritis].
    Prkacin I; Skurla B; Pocanić D; Bulum T; Bulimbasić S; Kardum-Skelin I
    Acta Med Croatica; 2011 Sep; 65 Suppl 1():217-21. PubMed ID: 23126056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatomegaly and cholestasis as primary clinical manifestations of an AL-kappa amyloidosis.
    Mohr A; Miehlke S; Klauck S; Röcken C; Malfertheiner P
    Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):921-5. PubMed ID: 10514129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphogenesis and course of renal amyloidosis].
    Tsykin DB; Shulutko BI; Zus' BA
    Ter Arkh; 1985; 57(6):53-6. PubMed ID: 4071413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AL-amyloidosis of the kidney initially presenting as minimal change glomerulonephritis.
    Hetzel GR; Uhlig K; Mondry A; Helmchen U; Grabensee B
    Am J Kidney Dis; 2000 Sep; 36(3):630-5. PubMed ID: 10977797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of primary amyloidosis by melphalan and prednisolone: a case report.
    Nakayama M; Kashiwagi M; Katafuchi R; Hori K; Hayashi S; Fujimi S
    Clin Nephrol; 2005 Mar; 63(3):215-20. PubMed ID: 15786823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and histologic findings in patients with renal amyloidosis].
    Rasić S; Cengić M; Golemac S; Uncanin S; Karamehić J
    Med Arh; 1996; 50(3-4):85-7. PubMed ID: 9601760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.
    Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV
    Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.